EXCIDRAH: Neuronal Excitability of HCN1 Channel Mutations in Dravet Syndrome

Sponsor
Fondation Ophtalmologique Adolphe de Rothschild (Other)
Overall Status
Recruiting
CT.gov ID
NCT02896608
Collaborator
(none)
110
1
84
1.3

Study Details

Study Description

Brief Summary

This study addresses the changes in the axonal excitability parameters. It will compare these changes in patients with early infantile epileptic encephalopathy with HCN1 channel mutation and in control patients, with and without epilepsy.

Condition or Disease Intervention/Treatment Phase
  • Device: measure of neuronal excitability

Study Design

Study Type:
Observational
Anticipated Enrollment :
110 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Neuronal Excitability of Hyperpolarization-activated Cyclic Nucleotide-gated (HCN1) Channel Mutations in Dravet Syndrome
Actual Study Start Date :
Oct 1, 2015
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Dravet syndrome - HCN1 channel mutation

early infantile epileptic encephalopathy with HCN1 channel mutation

Device: measure of neuronal excitability

control with epilepsy

Device: measure of neuronal excitability

control without epilepsy

Device: measure of neuronal excitability

Outcome Measures

Primary Outcome Measures

  1. hyperpolarizing electrotonus [baseline]

  2. hyperpolarizing threshold current [baseline]

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • early infantile epileptic encephalopathy with HCN1 channel mutation

  • control patients with no neurologic pathology (age, gender and body temperature matched)

  • epileptic patients (age, gender and body temperature matched)

Exclusion Criteria:
  • pregnant or breast feeding patient

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fondation Ophtalmologique Adolphe de Rothschild Paris France 75019

Sponsors and Collaborators

  • Fondation Ophtalmologique Adolphe de Rothschild

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fondation Ophtalmologique Adolphe de Rothschild
ClinicalTrials.gov Identifier:
NCT02896608
Other Study ID Numbers:
  • AGN_2015_11
First Posted:
Sep 12, 2016
Last Update Posted:
Dec 27, 2021
Last Verified:
Dec 1, 2021
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 27, 2021